🇺🇸 FDA
Patent

US 7947289

Multimeric protein toxins to target cells having multiple identifying characteristics

granted A61KA61K38/00A61K47/665

Quick answer

US patent 7947289 (Multimeric protein toxins to target cells having multiple identifying characteristics) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K38/00, A61K47/665, A61P, A61P19/04